|
|
???tair.name??? >
???browser.page.title.author???
|
"yang james chih hsin"???jsp.browse.items-by-author.description???
Showing items 26-50 of 101 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T15:17:32Z |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu;Wu, Shang-Gin;Hsieh, Min-Shu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; Tsai, Tzu-Hsiu;Wu, Shang-Gin;Hsieh, Min-Shu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; Tsai, T.-H. and Wu, S.-G. and Hsieh, M.-S. and Yu, C.-J. and Yang, J.C.H. and Shih, J.-Y.; 楊志新;余忠仁;謝明書;吳尚俊;蔡子修;施金元; MIN-SHU HSIEH; Tsai, Tzu-Hsiu; CHONG-JEN YU; Wu, Shang-Gin; Hsieh, Min-Shu; JIN-YUAN SHIH; Hsieh, Min-Shu; Yu, Chong-Jen; CHIH-HSIN YANG; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin; Shih, Jin-Yuan; Shih, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T14:49:59Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen, Yen-Fu;Hsieh, Min-Shu;Wu, Shang-Gin;Chang, Yih-Leong;Shih, Jin-Yuan;Liu, Yi-Nan;Tsai, Meng-Feng;Tsai, Tzu-Hsiu;Yu, Chong-Jen;Yang, James Chih-Hsin;Yang, Pan-Chyr; Chen, Y.-F. and Hsieh, M.-S. and Wu, S.-G. and Chang, Y.-L. and Shih, J.-Y. and Liu, Y.-N. and Tsai, M.-F. and Tsai, T.-H. and Yu, C.-J. and Yang, J.C.-H. and Yang, P.-C.; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;蔡子修;施金元; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;蔡子修;施金元; MIN-SHU HSIEH; Chen, Yen-Fu; Hsieh, Min-Shu; YIH-LEONG CHANG; Wu, Shang-Gin; CHONG-JEN YU; JIN-YUAN SHIH; Chang, Yih-Leong; CHIH-HSIN YANG; Shih, Jin-Yuan; Liu, Yi-Nan; Tsai, Meng-Feng; Tsai, Tzu-Hsiu; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T09:13:19Z |
Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR
|
Chung, Kuei-Pin;Wu, Shang-Gin;Wu, Jenn-Yu;Yang, James Chih-Hsin;Yu, Chong-Jen;Wei, Pin-Fei;Shih, Jin-Yuan;Yang, Pan-Chyr; Chung, K.-P. and Wu, S.-G. and Wu, J.-Y. and Yang, J.-H. and Yu, C.-J. and Wei, P.-F. and Shih, J.-Y. and Yang, P.-C.; 楊泮池 ;余忠仁 ;衛品妃 ;吳尚俊 ;施金元 ;巫震宇; Chong-Jen Yu; Chung, Kuei-Pin; Wu, Shang-Gin; PAN-CHYR YANG; KUEI-PIN CHUNG; Wu, Jenn-Yu; Yang, James Chih-Hsin; JIN-YUAN SHIH; Yu, Chong-Jen; Wei, Pin-Fei; Shih, Jin-Yuan; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T08:38:57Z |
Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition
|
Chu, H.-S. and Hu, F.-R. and Yang, C.-M. and Yeh, P.-T. and Chen, Y.-M. and Hou, Y.-C. and Chen, W.-L.; 朱筱桑;胡芳蓉;楊中美;葉伯廷;陳彥名;侯育致; CHU, HSIAO-SANG;HU, FUNG-RONG;YANG, CHUNG-MAY;YEH, PO-TING;CHEN, YAN-MING;HOU, YU-CHIH;CHEN, WEI-LI; YU-CHIH HOU; Lin, Yen-Ting; Wang, Yu-Fen; CHUNG-MAY YANG; WEI-LI CHEN; Yang, James Chih-Hsin; Yu, Chong-Jen; YAN-MING CHEN; Wu, Shang-Gin; PO-TING YEH; FUNG-RONG HU; Shih, Jin-Yuan; Yang, Pan-Chyr; CHU, HSIAO-SANG; HU, FUNG-RONG; YANG, CHUNG-MAY; YEH, PO-TING; CHEN, YAN-MING; HOU, YU-CHIH; CHEN, WEI-LI; ���ӷs; �����; �E����; �L����; �d�|�T; �I����; ������ |
| 臺大學術典藏 |
2018-09-10T06:48:43Z |
Recurrent advancing wavelike epitheliopathy from the opposite side of the initial presentation
|
FUNG-RONG HU; Chu, HS; Wu, Shang-Gin; I-JONG WANG; Hu, FR; Chang, Yih-Leong; Wang, IJ; Shih, Jin-Yuan; Hou, YC; Chen, WL.; Liu, Yi-Nan; Tsai, Meng-Feng; Tsai, Tzu-Hsiu; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 蔡子修; 施金元; Hsieh, Min-Shu; Chen, Yen-Fu; WEI-LI CHEN; Huang, YH; HUANG, YU-HSUN;CHU, HSIAO-SANG;HU, FUNG -RONG;WANG, I-JONG;HOU, YU-CHI;CHEN, WEI-LI; 黃昱勳;朱筱桑;胡芳蓉;王一中;侯鈺琪;陳偉勵; Huang, Y.-H. and Chu, H.-S. and Hu, F.-R. and Wang, I.-J. and Hou, Y.-C. and Chen, W.-L.; Huang, YH;Chu, HS;Hu, FR;Wang, IJ;Hou, YC;Chen, WL. |
| 國立臺灣大學 |
2016 |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu, Shang-Gin; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Yih-Leong; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, James Chih-Hsin; Wen, Yueh-Feng; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 溫岳峰; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2016 |
Efficacy of of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations
|
Chen, Yen-Fu; Hsieh, Min-Shu; Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 施金元 |
| 國立臺灣大學 |
2016 |
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
|
Liao, Bin-Chi; Lin, Chia-Chi; Lee, Jih-Hsiang; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 李日翔 |
| 國立臺灣大學 |
2016 |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen, Li-Yang; Molina-Vila, Miguel A.; Ruan, Sheng-Yuan; Su, Kang-Yi; Liao, Wei-Yu; Yu, Kai-Lun; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; Rosell, Rafael; Yang, Pan-Chyr; 楊志新; 蘇剛毅; 廖唯昱; 余忠仁; 何肇基; 阮聖元; 施金元 |
| 國立臺灣大學 |
2016 |
Safety of gefitinib in non-small cell lung cancer treatment
|
Hsiue, Emily Han-Chung; Lee, Jih-Hsiang; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 李日翔 |
| 國立臺灣大學 |
2016 |
Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
|
Liang, Yi-Hsin; Shao, Yu-Yun; Liao, Bin-Chi; Lee, Ho-Sheng; Yang, James Chih-Hsin; Chen, Ho-Min; Chiang, Chun-Ju; Cheng, Ann-Lii; Lai, Mei-Shu; 梁逸歆; 楊志新; 邵幼雲; 廖斌志; 賴美淑; 鄭安理 |
| 國立臺灣大學 |
2016 |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non-Small-Cell Lung Cancer: Analysis and Literature Review
|
Lin, Yen-Ting; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 林奕廷; 林怡岑; 施金元 |
| 國立臺灣大學 |
2016 |
Profile of the therascreen (R) EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer
|
Hsiue, Emily Han-Chung; Lee, Jih-Hsiang; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 李日翔 |
| 大葉大學 |
2015-04 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer.
|
Liu, Yi-Nan;Chang, Tzu-Hua;Tsai, Meng-Feng;Wu, Shang-Gin;Tsai, Tzu-Hsiu;Chen, Hsuan-Yu;Yu, Sung-Liang;Yang, James Chih-Hsin;Shih, Jin-Yuan |
| 國立臺灣大學 |
2015 |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu; Wu, Shang-Gin; Hsieh, Min-Shu; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 謝明書; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2015 |
Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma
|
Liao, Bin-Chi; Shao, Yu-Yun; Chen, Ho-Min; Shau, Wen-Yi; Lin, Zhong-Zhe; Kuo, Raymond Nienchen; Lai, Chiu-Ling; Chen, Kuo-Hsing; Cheng, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 廖斌志; 賴美淑; 林宗哲; 鄭安理; 郭年真; 陳國興 |
| 國立臺灣大學 |
2015 |
Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis
|
Hsu, Chia-Lin; Chen, Jen-Hau; Chen, Kuan-Yu; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; 楊志新; 楊泮池; 許嘉林; 陳冠宇; 余忠仁; 陳人豪; 施金元 |
| 國立臺灣大學 |
2015 |
First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M.
|
Tan, Daniel Shao-Weng; Seto, Takashi; Leighl, Natasha B.; Riely, Gregory J.; Sequist, Lecia V.; Felip, Enriqueta; Wolf, Juergen; Yang, James Chih-Hsin; Matushansky, Igor; Yu, Xiaolu; Schmitz, Shu-Fang Hsu; Cui, Xiaoming; Kim, Dong-Wan; 楊志新 |
| 國立臺灣大學 |
2015 |
How to use afatinib in clinical practice
|
Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2015 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Liu, Yi-Nan; Chang, Tzu-Hua; Tsai, Meng-Feng; Wu, Shang-Gin; Tsai, Tzu-Hsiu; Chen, Hsuan-Yu; Yu, Sung-Liang; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 俞松良; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2015 |
Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC).
|
Yang, James Chih-Hsin; Ahn, Myung-Ju; Dickgreber, Nicolas J.; Halmos, Balazs; Hirsh, Vera; Hochmair, Maximilian J.; Levy, Benjamin Philip; De Marinis, Filippo; Mok, Tony; O'Byrne, Kenneth; Okamoto, Isamu; Schuler, Martin H.; Sebastian, Martin; Shah, Riyaz N. H.; Tan, Eng-Huat; Yamamoto, Nobuyuki; Marten, Angela; Massey, Dan; Wind, Sven; Carbone, David Paul; 楊志新 |
| 國立臺灣大學 |
2015 |
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|
Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L.; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Orlov, Sergey; Mok, Tony; Boyer, Michael; Su, Wu-Chou; Lee, Ki Hyeong; Kato, Terufumi; Massey, Dan; Shahidi, Mehdi; Zazulina, Victoria; Sequist, Lecia V.; 楊志新 |
| 國立臺灣大學 |
2015 |
Maintenance therapy with gefitinib (G)/pemetrexed (P) versus P alone after induction therapy with P/platinum for metastatic lung adenocarcinoma (MLADC) harboring no sensitizing epidermal growth factor receptor mutation (sEGFRm): A phase II multicenter randomized open-label study (GENIUS trial).
|
Tsai, Chun-Ming; Lai, Chun-Liang; Chiu, Chao-Hua; Hsia, Te-Chun; Chen, Chen-Hsin; Chang, Gee-Chen; Shih, Jin-Yuan; Ho, Ching-Liang; Chen, Yuh-Min; Yang, James Chih-Hsin; 楊志新; 施金元 |
| 國立臺灣大學 |
2015 |
Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
|
Tang, Mei-Chuan; Wu, Mei-Yi; Hwang, Ming-Hung; Chang, Ya-Ting; Huang, Hui-Ju; Lin, Anya Maan-Yuh; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2015 |
A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results.
|
Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil; 林家齊; 楊志新 |
Showing items 26-50 of 101 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
|
